SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001493152-20-010299
Filing Date
2020-06-01
Accepted
2020-06-01 17:29:01
Documents
1
Period of Report
2020-05-22

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 5125
  Complete submission text file 0001493152-20-010299.txt   6956
Mailing Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121
Business Address 11750 SORRENTO VALLEY ROAD SUITE 250 SAN DIEGO CA 92121 (858) 436-1000
Gene Biotherapeutics, Inc. (Issuer) CIK: 0000772320 (see all company filings)

IRS No.: 840635673 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 1370 HAMILTON STREET SOMERSET NJ 08873
Business Address 1370 HAMILTON STREET SOMERSET NJ 08873 732-543-2440
Nostrum Pharmaceuticals, LLC (Reporting) CIK: 0001811885 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33635 | Film No.: 20934834